Updates matching "Access to Biomarker Testing"

BUFFALO, NY – November 8, 2023 – Earlier today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of

HARRISBURG, PA – OCTOBER 12, 2023 – Today, Rep. Kyle Mullins introduced House Bill 1754 to increase Pennsylvanians’ access to biomarker testing, following Sen. Devlin Robinson’s introduction of a companion bill, Senate Bill 954, in the Senate last week. A game-changing part of cancer care, biomarker testing opens the door

California Governor Gavin Newsom announced he has signed Senate Bill 496, ensuring that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing when supported by medical and scientific evidence.

FORT MYERS, FL -- The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a child’s wedding or the birth of a grandchild. The oncology world is witnessing a transformative phase with

The California Legislature passed a bill to ensure that more health insurance plans, including Medi-Cal, cover comprehensive biomarker testing . Senate Bill 496, sponsored by ACS CAN and the University of California, now heads to the governor’s desk.

ALBANY, NY – JUNE 9, 2023 – Late last night, the New York State Assembly passed Assembly Bill 1673a to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Hochul’s desk, providing her the opportunity to

Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.

LAS VEGAS, NEV. – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.

Gov. Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.